Echo Therapeutics (ECTE) Posts Narrower Q3 Loss
Tweet
Share
E-mailGet Alerts ECTE Hot Sheet
Join SI Premium – FREE
Echo Therapeutics (NASDAQ: ECTE) reported Q3 EPS of ($0.43), versus ($0.49) reported last year. Revenue for the quarter came in at $19.11 million, versus $22.56 million reported last year.
For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron reports Q4 today: Why Lynx Equity sees massive upside
- HSBC Upgrades Target (TGT) to Buy
- Hermes stock target lowered at Citi on continued China weakness
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
